Back to results
CompletedPhase 2

24 Months Safety and Efficacy Study of AADvac1 in Patients With Mild Alzheimer's Disease

NCT02579252

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Ordination Dr. Bancher

Horn, Lower Austria, Austria

+41 additional locations

View on ClinicalTrials.gov
24 Months Safety and Efficacy Study of AADvac1 in Patients With Mild Alzheimer's Disease — TrialFind